Effects of Delaying FK506 Administration on Neuroregeneration in a Rodent Model

ABSTRACT

FK506 is an immunosuppressant drug that has been shown experimentally to stimulate nerve growth and speed functional recovery, when administered immediately after peripheral nerve injury. However, the clinical scenario of a peripheral nerve injury is often associated with either a delayed diagnosis or reconstruction. The purpose of this study was to determine the efficacy of FK506 on neuroregeneration with delayed administration. Thirty-two Lewis rats underwent tibial nerve transection with immediate repair. Animals were left untreated, or were treated with daily injections of FK506 (2 mg/kg), started on the day of surgery, postoperative day 3, or postoperative day 5. Animals underwent walking track analysis to assess functional nerve recovery. Nerves were harvested for histomorphometric analysis on postoperative days 21, 28, and 42. Histomorphometry demonstrated that all treatment groups, regardless of the time of drug initiation, demonstrated evidence of enhanced neuroregeneration, compared to the untreated group. Histomorphometric data from groups harvested on day 21 demonstrated a statistically significant improvement in neuroregeneration in the immediate and 3-day delay groups. Therefore, the beneficial effects of FK506 on neuroregeneration are not restricted to immediate administration, but these effects significantly diminish when FK506 is administered 3 days after nerve injury.

KEYWORDS

FK506 - neuroregeneration - delay

REFERENCES

• 1 Kobayashi J, Mackinnon S E, Watanabe O. et al . The effect of duration of muscle denervation on functional recovery in the rat model.  Muscle Nerve . 1997;  20 858-866
• 2 Doolabh V, Mackinnon S E. FK506 accelerates functional recovery following nerve grafting in a rat model.  Plast Reconstr Surg . 1999;  103 1928-1935
• 3 Gold B G, Storm-Dickerson T, Austin D R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury.  Restor Neurol Neurosci . 1994;  6 287-296
• 4 Gold B G, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve.  J Neurosci . 1995;  15 7509-7516
• 5 Jost S C, Doolabh V, Lee M, Hunter D, Mackinnon S E. Acceleration of peripheral nerve regeneration following FK506 administration.  Restor Neurol Neurosci . 2000;  17 1-6
• 6 Hare G MT, Evans P J, Mackinnon S E. et al . Walking track analysis: a long-term assessment of peripheral nerve recovery.  Plast Reconstr Surg . 1992;  89 251-258
• 7 Schreiber S L, Crabtree G R. The mechanism of action of cyclosporine A and FK506.  Immunol Today . 1992;  13 136-142
• 8 Lee M, Doolabh V B, Mackinnon S E, Jost S. FK506 promotes functional recovery in crushed rat sciatic nerve.  Muscle Nerve . 2000;  23 633-640
• 9 Sabatini D M, Lai M M, Snyder S H. Neural roles of immunophilins and their ligands.  Molec Neurobiol . 1997;  15 223-239
• 10 Dawson T M, Steiner J P, Lyons W E. et al . The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin.  Neuroscience . 1994;  62 569-580
• 11 Spies J M, Westland K W, Bonner J G, Pollard J D. Intraneural activated T cells cause focal breakdown of the blood nerve barrier.  Brain . 1995;  118 857-868
• 12 Lyons W E, Steiner J P, Snyder S H, Dawson T M. Neuronal regeneration enhances the expression of the immunophilin FKBP-12.  J Neurosci . 1995;  15 2985-2994
• 13 Gold B G, Yew J Y, Zeleny-Pooley M. The immunosuppressant FK506 increases GAP-43 mRNA levels in axotomized sensory neurons.  Neurosci Let . 1998;  241 25-28
• 14 Skene J H, Virag I. Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43.  J Cell Biology . 1989;  108 613-624
• 15 Benowitz L I, Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity.  Trends Neurosci . 1997;  20 84-91
• 16 Kater S B, Mills L B. Regulation of growth cone behavior by calcium.  J Neurosci . 1991;  11 891
• 17 Cameron A M, Steiner J P, Roskams A J. et al . Calcineurin associated with the inositol 1,4,5-triphosphate receptor-FKBP12 complex modulates Ca2+ flux.  Cell . 1995;  83 463-472
• 18 Takei K, Jay D G, Mikoshiba K. Regional laser inactivation of type 1 inositol 1,4,5-triphosphate receptor affects growth cone morphology and motility in chick DRG neurons.  Soc Neurosci Abstracts . 1996;  22 740
• 19 Gold B G, Zeleny-Pooley M, Wang M-S, Chaturvedi P, Armistead D M. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration.  Experi Neurol . 1997;  147 269-278
• 20 Steiner J P, Hamilton G S, Ross D T. et al . Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.  Proceed Nat Acad Sci USA . 1997;  94 2019-2024
• 21 Gold B G, Densmore V, Shou W. et al . Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506.  J Pharmacol Experiment Therapeut . 1999;  289 1202-1210
• 22 Gold B G, Storm-Dickerson T, Austin D R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury.  Restorative Neurol Neurosci . 1994;  6 287-296
• 23 Doolabh V, Mackinnon S E. FK506 accelerates functional recovery following nerve grafting in a rat model.  Plast Reconstr Surg . 1999;  103 1928-1935
• 24 Gold B G, Gordon H S, Wang M-S. Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect.  Neurosci Let . 1999;  267 33-36
• 25 Sulaiman O AR, Voda J, Gold B G, Gordon T. FK506 increases nerve regeneration after chronic motoneuron axotomy but not after chronic Schwann cell denervation.  Experimental Neurology . 2002;  175 127-137